Evidence mapPaperPMID 39337465Full record

ReviewInternational journal of molecular sciences2024

Interactions of SARS-CoV-2 with Human Target Cells-A Metabolic View.

Wolfgang Eisenreich, Julian Leberfing, Thomas Rudel, Jürgen Heesemann, Werner Goebel

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wolfgang EisenreichStructural Membrane Biochemistry, Bavarian NMR Center (BNMRZ), Department of Bioscience, TUM School of Natural Sciences, Technical University of Munich, Lichtenbergstr. 4, 85747 Garching, Germany.ORCID 0000-0002-9832-8279
Julian LeberfingStructural Membrane Biochemistry, Bavarian NMR Center (BNMRZ), Department of Bioscience, TUM School of Natural Sciences, Technical University of Munich, Lichtenbergstr. 4, 85747 Garching, Germany.ORCID 0009-0001-3549-5731
Thomas RudelChair of Microbiology, Biocenter, University of Würzburg, 97074 Würzburg, Germany.
Jürgen HeesemannMax von Pettenkofer Institute, Ludwig Maximilian University of Munich, 80336 München, Germany.
Werner GoebelMax von Pettenkofer Institute, Ludwig Maximilian University of Munich, 80336 München, Germany.

Funding

Deutsche Forschungsgemeinschaft EI 384/16 and RU631/17
6 · The paper itself

Abstract

Viruses are obligate intracellular parasites, and they exploit the cellular pathways and resources of their respective host cells to survive and successfully multiply. The strategies of viruses concerning how to take advantage of the metabolic capabilities of host cells for their own replication can vary considerably. The most common metabolic alterations triggered by viruses affect the central carbon metabolism of infected host cells, in particular glycolysis, the pentose phosphate pathway, and the tricarboxylic acid cycle. The upregulation of these processes is aimed to increase the supply of nucleotides, amino acids, and lipids since these metabolic products are crucial for efficient viral proliferation. In detail, however, this manipulation may affect multiple sites and regulatory mechanisms of host-cell metabolism, depending not only on the specific viruses but also on the type of infected host cells. In this review, we report metabolic situations and reprogramming in different human host cells, tissues, and organs that are favorable for acute and persistent SARS-CoV-2 infection. This knowledge may be fundamental for the development of host-directed therapies.

Indexed as

COVID-19SARS-CoV-2Citric Acid CycleGlycolysisHost-Pathogen InteractionsHumansPentose Phosphate PathwayVirus ReplicationCOVID-19host-directed therapieslong COVIDmetabolic reprogrammingpersistenceSARS-CoV-2

Identifiers

PMID39337465
PMCPMC11432161

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.